A positive association was found between osteoarthritis and overactive bladder (OAB), but rheumatoid arthritis and psoriatic ...
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Understanding the link between gut health and psoriasis opens new avenues for treatment and highlights the need for comprehensive care approaches that encompass both dermatological and gastrointestina ...
WBAL TV Baltimore on MSN4d
Woman's Doctor: Reasons behind rheumatoid arthritis, how to treat itRheumatoid arthritis (RA) is an autoimmune disease, an inflammatory arthritis, that often can present with much joint pain ...
Everyday Health on MSN4d
Understanding Disease Progression in Rheumatoid ArthritisUnderstand RA from early to advanced stages. Explore symptoms, treatments, and lifestyle tips to manage rheumatoid arthritis ...
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...
The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.
Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback